KL2 Training Program

Current & Past Scholars

The following are brief biographies of the scholars selected for each award year. As you can see, they represent broad disciplinary diversity and bring impressive and relevant training and experience to the CASE/Cleveland Clinic CTSC KL2.

Cohort 1 (2005) | Cohort 2 (2006) | Cohort 3 (2007) | Cohort 4 (2008) | Cohort 5 (2009)
| Cohort 6 (2010) | Cohort 7 (2011) | Cohort 8 (2012) | Cohort 9 (2013) | Cohort 10 (2014) | Cohort 11 (2015) | Cohort 12 (2016)

Cohort 6 (2010)

Jinbo Fan, Ph.D.
Dr. Fan received his B.S. in Biotechnology from Sichuan University and his Ph.D. in Neurobiology from the Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences in China. He completed his postdoctoral training in psychiatric genetics at The Broad Institute of MIT and Harvard. Dr. Fan has received numerous honors including a Charles A. King Trust Postdoctoral Fellowship from The Medical Foundation (TMF) and a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD). Dr. Fan's career goal is to achieve significant scientific breakthroughs through the design and conduct of methodologically innovative clinical research on the genetic and molecular basis of serious mental illness with a primary focus on bipolar disorder. As a KL2 Clinical Research Scholar, he plans to take a systematic three-stage approach to comprehensive and systematic assessment of the putative genetic risk factors in the phenomenology and treatment of bipolar disorder. Dr. Fan will become a faculty member at the Case Western Reserve University School of Medicine in July 2010 with joint appointments within the Department of Epidemiology and Biostatistics and the Department of Psychiatry.

Thomas Frazier, Ph.D.
Dr. Frazier received his B.S in Psychology from John Carroll University and his M.A. and Ph.D. in Clinical Psychology from Case Western Reserve University. He completed his internship at the Ann Arbor VA Medical Center, one year of a post-doctoral fellowship in neuropsychology at the Cleveland Clinic Foundation, and was a Visiting Assistant Professor at John Carroll University. Since 2006, Dr. Frazier has been a staff member in the Center for Pediatric Behavioral Health and the Center for Autism at the Cleveland Clinic. His clinical expertise includes assessment and differential diagnosis in children and adolescents suspected of having disruptive behavior or autism spectrum disorders. Dr. Frazier's research examines phenotypic and structural neural abnormalities in youth with autism spectrum disorders. His KL2 Multidisciplinary Clinic Research Training Program project, conducted in conjunction with Dr. Charis Eng and the Genomic Medicine Institute, examines the downstream neural and cognitive consequences of mutations in PTEN and related pathway genes in children with autism.

Sankar Dass Navaneethan, M.D., M.P.H.
Dr. Navaneethan earned his medical degree from Madras Medical College, Madras, India, and his M.P.H. from the University of South Carolina. He completed his residency in Internal Medicine and clinical fellowship in Nephrology at the University of Rochester, Rochester, NY in June 2008. He is currently an Associate Staff at the Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute. His research interests include: obesity and outcomes in chronic kidney disease (CKD), referral to nephrologists for CKD care and systematic reviews and clinical trials in nephrology. His career goals are to become an expert in the field of obesity and kidney disease, and clinical trials in nephrology. As a KL2 Clinical Research Scholar, he plans to conduct a prospective study to assess the impact of various weight loss interventions in patients with chronic kidney disease. His other ongoing projects include development of a chronic kidney disease registry at Cleveland Clinic which would house details of over 40,000 kidney disease patients for research studies and systematic reviews relating to various topics in nephrology through his work with Cochrane Renal Group.

Melissa Young, Ph.D.
Dr. Young received her BS in Materials Engineering from California Polytechnic State University, San Luis Obispo and her Ph.D. in Materials Science and Engineering from the University of California, Irvine. Dr. Young has more than eight years of industry experience with cardiovascular medical devices. As a Senior Engineer at Edwards Lifesciences Inc., she conducted research on biomaterial implant alloys that involved both material processing and characterization with an emphasis on fatigue performance, corrosion, and biocompatibility. She continued her engineering leadership as a Principal Engineer for Medtronic Inc., where she established advanced computational modeling and simulation capability to study stent and tissue failure mechanisms. Since 2009, Dr. Young has taken a Research position in the Biomedical Engineering Department of the Cleveland Clinic, where she is a part of the Medical Device Solutions group and works directly with clinicians to develop new therapeutic technologies. As a KL2 Clinical Research Scholar, Dr. Young will continue to collaborate with physicians to develop realistic in vitro and in silico evaluation methods used to establish performance of peripheral vascular stents, to determine key design features that optimize their in vivo behavior, and to establish fatigue criteria that enable designers to improve the durability and ultimately long term patient care.